Journal article
Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia
LN Varghese, JG Zhang, SN Young, TA Willson, WS Alexander, NA Nicola, JJ Babon, JM Murphy
Growth Factors | INFORMA HEALTHCARE | Published : 2014
Abstract
Activation of the cell surface receptor, c-Mpl, by the cytokine, thrombopoietin (TPO), underpins megakaryocyte and platelet production in mammals. In humans, mutations in c-Mpl have been identified as the molecular basis of Congenital Amegakaryocytic Thrombocytopenia (CAMT). Here, we show that CAMT-associated mutations in c-Mpl principally lead to defective receptor presentation on the cell surface. In contrast, one CAMT mutant c-Mpl, F104S, was expressed on the cell surface, but showed defective TPO binding and receptor activation. Using mutational analyses, we examined which residues adjacent to F104 within the membrane-distal cytokine receptor homology module (CRM) of c-Mpl comprise the T..
View full abstractGrants
Funding Acknowledgements
L.N.V. acknowledges scholarships from the Leukaemia Foundation of Australia and the Australian Stem Cell Centre.